Lung Cancer Screening and Tobacco Cessation ECHO

February 2020 - October 2021

Restarting a Lung Cancer Screening Program in a Post-COVID-19 World
This session provided an overview of how one system (Vanderbilt) reopened their lung cancer screening program after the height of the COVID-19 pandemic. This included topics on risk mitigation, rescheduling appointments, and the use of telemedicine for shared decision-making.

Didactic Presenter: Kim Sandler, MD

View Resources:
Lung Cancer Screening and Tobacco Cessation ECHO - 6-23-2020 - Recording
Perceived Risks: What Patients Really Think About Lung Cancer Screening
This session will help participants better understand what makes patients decide to receive lung cancer screening or decline to receive their screening. It will also introduce the notion of stigma and bias and how both factor into a patient’s decision to screen or not to screen. There will also be discussion around how the stress of COVID-19 may make it difficult for individuals to quit smoking.

Didactic Presenter: Lisa Carter-Harris, PhD, APRN, ANP-C, FAAN

View Resources:
Lung Cancer Screening and Tobacco Cessation ECHO - 7-28-2020 - Recording

Our Experts

Andrea Borondy Kitts MS, MPH

Lahey Hospital & Medical Center
Patient Outreach & Research Specialist

Durado Brooks, MD, MPH

Former Vice President, Prevention and Early Detection

Lisa Carter-Harris, PhD, APRN, ANP-C, FAAN

Memorial Sloan Kettering Cancer Center
Associate Attending Behavioral Scientist
Associate Research Director, Tobacco Research, Training & Treatment Lab

Richard Hoffman, MD, MPH

University of Iowa Carver College of Medicine
Co-Leader, Cancer Epidemiology Population Science Program
Director, Division of General Internal Medicine
Professor of Internal Medicine - General Internal Medicine

Jose Leon, MD, MPH

National Center for Health in Public Housing
Medical Director

Laura Makaroff, DO

Senior Vice President
Cancer Prevention and Survivorship

Jamie Ostroff, PhD

Chief, Behavioral Sciences Service
Director, Tobacco Treatment Program

Kim Sandler, MD

Vanderbilt Health
Co-Director, Vanderbilt Lung Screening Program
Assistant Professor of Radiology and Radiological Sciences

Joan Schiller, MD

University of Virginia
Lung Cancer Research Foundation
Adjunct Professor

Robert Smith, PhD, FSBI

Senior Vice President, Cancer Screening

Jamie Studts, PhD

University of Colorado Denver - Anschutz Medical Campus
Co-Leader of the CU Cancer Center Cancer Prevention & Control Program
Visiting Professor, Medicine-Medical Oncology

Francis Vitale, MA

Pharmacy Partnership for Tobacco Cessation
National Director
Clinical Assistant Professor

Lung Cancer Screening and Tobacco Cessation ECHO

Session 1 - February 18, 2020 - Lung Cancer Screening Research and Guidelines

Session 2 - June 23, 2020 - Restarting a Lung Cancer Screening Program in a Post-COVID-19 World

Session 3 - July 28, 2020 - Perceived Risks: What Patients Really Think About Lung Cancer Screening

Session 4 - August 25, 2020 - Lung Cancer Screening and Health Disparities

Session 5 - September 22, 2020 - Shared Decision-Making and Decision Aids

Session 6 - October 27, 2020 - Tobacco Cessation in the Context of Lung Cancer Screening

Session 7 - January 26, 2021 - Adopting Empathic Communication in the Context of Assessing Smoking Behavior

Session 8 - February 23, 2021 - Proven Smoking Cessation Interventions, Resources, and Cessation Medication

Session 9 - March 23, 2021 - Survivorship: How Stigma and Nihilism Influences Quality of Life, Cancer Care and Prognosis

Session 10 - April 27, 2021 - Lung Cancer Screening: A teachable moment to help smokers quit

Session 11 - June 22, 2021 - Lung Nodule Management

Session 12 - July 27, 2021 - Motivational Interviewing

Session 13 - August 24, 2021 - USPSTF Final Lung Cancer Screening Recommendations: Impact and Implications

Session 14 - October 26, 2021 - Top Tips to Sustain Success in Your Lung Cancer Screening Programs